Representing the ninth acquisition for W2O in just over a year, the company said the acquisitions show its commitment to technology and the role it will play in the future of healthcare.
As part of the announcement, W20 has established a new health tech division that combines W2O’s data and analytics software with the Symplur, Swoop and IPM.ai tech and data assets.
W2O said it has evolved its business and made big bets on tech-enablement over the past few years adding that this is another milestone in its transformation to a healthcare innovation company.
In a statement, W20 said Swoop and IPM.ai are pioneers in using machine learning, artificial intelligence, and real-world data to solve big challenges in healthcare.
Swoop creates precise patient audiences, improving targeting of healthcare engagement and empowering patients to become active participants in their treatment journey.
IPM.ai uncovers the ideal patient, enabling accelerated research, development, and marketing of life-saving therapies in under-defined patient populations.
W20 has been on the acquisition trail since it announced a partnership with New Mountain Capital in 2019.
The company achieved revenues of more than $350 million in 2020, an increase of 50% from the previous year.
W20 was founded in 2001 by Jim Weiss and now employs 1,500 people, using analytics and technology to build insights for clients in the life sciences industry.
The post W20 acquires data technology firms Swoop and IPM.ai appeared first on .